© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Vanguard Health Care Fund Admiral Shares (VGHAX) stock declined over -0.68%, trading at $87.18 on NASDAQ, down from the previous close of $87.78. The stock opened at $87.78, fluctuating between $87.18 and $87.78 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 87.78 | 87.78 | 87.18 | 87.18 | 0 |
| Sep 09, 2026 | 88.35 | 88.35 | 87.78 | 87.78 | 0 |
| Sep 08, 2026 | 90.30 | 90.30 | 88.35 | 88.35 | 0 |
| Sep 04, 2026 | 91.39 | 91.39 | 90.30 | 90.30 | 0 |
| Sep 03, 2026 | 90.37 | 91.39 | 90.37 | 91.39 | 0 |
| Sep 02, 2026 | 90.37 | 91.12 | 90.37 | 91.12 | 0 |
| Sep 01, 2026 | 89.75 | 90.37 | 89.75 | 90.37 | 0 |
| Aug 31, 2026 | 90.01 | 90.01 | 89.75 | 89.75 | 0 |
| Aug 28, 2026 | 90.75 | 90.75 | 90.01 | 90.01 | 0 |
| Aug 27, 2026 | 91.64 | 91.64 | 90.75 | 90.75 | 0 |
| Aug 26, 2026 | 92.45 | 92.45 | 91.64 | 91.64 | 0 |
| Aug 25, 2026 | 91.64 | 92.45 | 91.64 | 92.45 | 0 |
| Aug 24, 2026 | 91.96 | 91.96 | 91.64 | 91.64 | 0 |
| Aug 21, 2026 | 90.88 | 91.96 | 90.88 | 91.96 | 0 |
| Aug 20, 2026 | 92.70 | 92.70 | 90.88 | 90.88 | 0 |
| Aug 19, 2026 | 89.32 | 92.70 | 89.32 | 92.70 | 0 |
| Aug 18, 2026 | 88.29 | 89.32 | 88.29 | 89.32 | 0 |
| Aug 17, 2026 | 88.02 | 88.29 | 88.02 | 88.29 | 0 |
| Aug 14, 2026 | 88.36 | 88.36 | 88.02 | 88.02 | 0 |
| Aug 13, 2026 | 88.96 | 88.96 | 88.36 | 88.36 | 0 |
Malvern, PA 19355
United States
https://investor.vanguard.com/investment-products/mutual-funds/profile/vghax610 669 1000For over a quarter-century, this actively managed portfolio has offered investors an economical gateway to companies worldwide operating within the healthcare sector. Its holdings encompass pharmaceutical giants, medical equipment manufacturers, and cutting-edge research organizations. Compared to its peers in the healthcare space, this fund typically exhibits broader international exposure and a lower portfolio turnover rate. Nevertheless, investors should acknowledge the inherent concentration risk, as it exclusively targets the health care industry. Given that annual returns can fluctuate significantly, this fund is best suited as a supplementary component within a well-diversified investment strategy, particularly for those with a lengthy time horizon.
| Employees | 0 |
| Beta | 0.55 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management |